ASX: AAJ · Five-year financial review

(ASX: AAJ) Aruma Resources Financial Review - FY2021~25

Aruma’s cash and equity record shows an exploration company funding work and portfolio changes rather than generating mine sales. The latest year brought new copper and uranium exposure, further equity funding and continued cash consumption.

Years ended 30 June 2021-2025 · consolidated A$ million · Editorial review: 2026-09-28 · MII Research

Reading the figures: Units are stated by table or metric. Brackets denote negative amounts. Supported nil is zero; unlike reporting bases remain separately labelled.

FY2025 cash
A$0.861m

Before any later funding.

FY2025 net loss
A$2.103m

Statutory, excluding other comprehensive expense.

FY2025 operating outflow
A$2.095m

Includes exploration cash expenditure.

FY2025 equity
A$1.961m

Consolidated accounting equity.

Five years in context

The early portfolio emphasised Western Australian gold and lithium exploration. The NHM transaction subsequently added copper and uranium tenements in Queensland and South Australia. A portfolio transaction is not a commercial mine start-up.

Equity funding replenished cash in FY2022, followed by three lower year-end cash balances. This is an exploration funding cycle, not a mine-sales growth series. Exploration expense and exploration cash payments measure different things.

Events behind the numbers

FY2021

Funding and portfolio disposal

Two raisings provided A$3.052m gross. The Slate Dam/Trojan and Clinker Hills disposal generated A$0.500m cash consideration, distinct from an accounting gain.

FY2022

Placements funded exploration

Two placements raised A$4.660m before issue costs; the company also received a A$0.459m R&D tax incentive. These funded exploration and working capital rather than mine production.

FY2023

Exploration spending absorbs funds

FY2024 comparative statements record A$2.512m exploration expense and A$3.522m operating cash outflow for FY2023; neither is a capitalised resource valuation.

FY2024

New portfolio proposed

The copper and uranium transaction was announced in May 2024. Shareholder approval on 1 August falls in FY2025, rather than proving completion before June.

FY2025

Acquisition and funding

The NHM acquisition used settlement shares and milestone options. A separate A$0.900m placement funded the company; Piper maiden drilling began after year end.

FINANCIAL REVIEW / 01

Five years of cash and equity

Cash and equity rose in the placement-funded FY2022 year, then declined through FY2025 as exploration and overheads continued. Accounting equity is not a mineral resource valuation.

Cash at 30 June

A$ million

Cash at 30 JuneCash and cash equivalents: FY2021 2.692; FY2022 4.701; FY2023 3.155; FY2024 2.144; FY2025 0.86101.322.633.955.27FY2021FY2022FY2023FY2024FY2025Cash and cash equivalents, FY2021: 2.692 A$ million2.692Cash and cash equivalents, FY2022: 4.701 A$ million4.701Cash and cash equivalents, FY2023: 3.155 A$ million3.155Cash and cash equivalents, FY2024: 2.144 A$ million2.144Cash and cash equivalents, FY2025: 0.861 A$ million0.861
Cash and cash equivalents
Five identified same-company balance-date observations.

AI-generated presentation · values from Cash and equity over five balance dates; no missing values plotted as zero.

Consolidated equity

A$ million

Consolidated equityConsolidated total equity: FY2021 2.706; FY2022 4.259; FY2023 3.286; FY2024 2.250; FY2025 1.96101.192.393.584.77FY2021FY2022FY2023FY2024FY2025Consolidated total equity, FY2021: 2.706 A$ million2.706Consolidated total equity, FY2022: 4.259 A$ million4.259Consolidated total equity, FY2023: 3.286 A$ million3.286Consolidated total equity, FY2024: 2.250 A$ million2.250Consolidated total equity, FY2025: 1.961 A$ million1.961
Consolidated total equity
Accounting equity; not market value or mineral resource value.

AI-generated presentation · values from Cash and equity over five balance dates; no missing values plotted as zero.

Cash and equity over five balance dates

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Cash and cash equivalents2.6924.7013.1552.1440.861
Consolidated total equity2.7064.2593.2862.2501.961

FY2022 is established from the opening FY2023 cash/equity values in the FY2024 report: 1 July 2022 balances correspond to the preceding 30 June. FY2023 uses the same company’s FY2024 comparatives, not the foreign-company FY2023 slice.

A bounded check of Aruma’s own FY2022 parsed financial statements also corroborates cash A$4,701,408 and equity A$4,259,327. Foreign-company tables linked to that document were not used.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 02

Exploration expense is central to the loss

The accounting policy expenses ongoing exploration but capitalises licence acquisition costs. The new exploration asset balance and current-year exploration expense therefore measure different activities. The latest loss cannot be described as simply cash used or investment capitalised.

Statutory net loss

A$ million

Statutory net lossStatutory net loss: FY2021 (1.596); FY2022 (3.242); FY2023 (3.045); FY2024 (1.126); FY2025 (2.103)-3.44-2.48-1.52-0.570.39FY2021FY2022FY2023FY2024FY2025Statutory net loss, FY2021: (1.596) A$ million(1.596)Statutory net loss, FY2022: (3.242) A$ million(3.242)Statutory net loss, FY2023: (3.045) A$ million(3.045)Statutory net loss, FY2024: (1.126) A$ million(1.126)Statutory net loss, FY2025: (2.103) A$ million(2.103)
Statutory net loss
Statutory net loss, excluding other comprehensive movements. FY2022 recovered from Aruma’s parsed statements.

AI-generated presentation · values from Exploration expenses and statutory loss; no missing values plotted as zero.

Exploration charged to earnings

A$ million

Exploration charged to earningsExploration expense: FY2021 (0.887); FY2022 (1.887); FY2023 (2.512); FY2024 (0.941); FY2025 (1.184)-2.66-1.92-1.18-0.440.3FY2021FY2022FY2023FY2024FY2025Exploration expense, FY2021: (0.887) A$ million(0.887)Exploration expense, FY2022: (1.887) A$ million(1.887)Exploration expense, FY2023: (2.512) A$ million(2.512)Exploration expense, FY2024: (0.941) A$ million(0.941)Exploration expense, FY2025: (1.184) A$ million(1.184)
Exploration expense
Expense, not capitalised acquisition costs or cash exploration payments.

AI-generated presentation · values from Exploration expenses and statutory loss; no missing values plotted as zero.

Exploration expenses and statutory loss

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Other income0.2380.4590.8371.1460.425
Exploration expense(0.887)(1.887)(2.512)(0.941)(1.184)
Statutory net loss(1.596)(3.242)(3.045)(1.126)(2.103)

FY2025 statutory income lines use correction decisions already saved on 24 September 2026. Loss excludes other comprehensive expense; the two are not interchangeable.

FY2021 lease-disposal proceeds/gain are not recurring mineral sales, and are not merged into an operating-revenue growth chart. The extraction contains conflicting disposal-gain presentations, so no synthetic revenue trend is constructed.

FY2022 was recovered from Aruma’s existing parsed consolidated statements. Exploration expense A$1,886,652 is not the A$1,557,768 exploration cash payment. Net loss is distinct from total comprehensive loss.

Source: Annual extractions plus the bounded Aruma FY2022 parsed-statement recovery; editions listed once below.

FINANCIAL REVIEW / 03

Capital receipts did not cover the latest operating outflow

Equity cash receipts and the R&D tax incentive provided funding, but exploration and supplier payments continued. Cash-flow issue costs exclude non-cash option transfers inside equity. The directors and auditor identified a material going-concern uncertainty dependent on further capital.

Operating cash versus net financing

A$ million

Operating cash versus net financingOperating cash flow: FY2021 (1.793); FY2022 (2.309); FY2023 (3.522); FY2024 (0.984); FY2025 (2.095) | Net financing cash flow: FY2021 2.850; FY2022 4.338; FY2023 2.075; FY2024 (0.019); FY2025 0.814-3.99-1.670.642.965.28FY2021FY2022FY2023FY2024FY2025Operating cash flow, FY2021: (1.793) A$ millionOperating cash flow, FY2022: (2.309) A$ millionOperating cash flow, FY2023: (3.522) A$ millionOperating cash flow, FY2024: (0.984) A$ millionOperating cash flow, FY2025: (2.095) A$ millionNet financing cash flow, FY2021: 2.850 A$ millionNet financing cash flow, FY2022: 4.338 A$ millionNet financing cash flow, FY2023: 2.075 A$ millionNet financing cash flow, FY2024: (0.019) A$ millionNet financing cash flow, FY2025: 0.814 A$ million
Operating cash flowNet financing cash flow
Operating cash versus financing cash flows; statement values retained where tiny reconciliation differences are disclosed.

AI-generated presentation · values from Cash movement: supported annual observations; no missing values plotted as zero.

Selected FY2025 cash sources and uses

A$ million

Selected FY2025 cash sources and usesR&D tax incentive receipts: FY2025 0.415 | Exploration cash expenditure: FY2025 (1.179) | Supplier and employee payments: FY2025 (1.385) | Gross equity cash receipts: FY2025 0.900-1.52-0.85-0.170.51.17FY2025R&D tax incentive receipts, FY2025: 0.415 A$ millionExploration cash expenditure, FY2025: (1.179) A$ millionSupplier and employee payments, FY2025: (1.385) A$ millionGross equity cash receipts, FY2025: 0.900 A$ million
R&D tax incentive receiptsExploration cash expenditureSupplier and employee paymentsGross equity cash receipts
Selected independent components, not total cash movement.

AI-generated presentation · values from FY2025 operating and funding components; no missing values plotted as zero.

Cash movement: supported annual observations

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Operating cash flow(1.793)(2.309)(3.522)(0.984)(2.095)
Net financing cash flow2.8504.3382.075(0.019)0.814

FY2022 uses the consolidated cash-flow statement: operating outflow A$2,309,149 and financing inflow A$4,338,216. The operating reconciliation differs by A$1 (A$2,309,148); the statement is retained. FY2024 similarly retains the statement A$983,657 rather than the reconciliation A$983,654.

FY2025 cash decreased despite A$0.900m gross equity receipts; net financing was lower after cash issue costs and lease repayments.

Source: Annual extractions plus the bounded Aruma FY2022 parsed-statement recovery; editions listed once below.

FY2025 operating and funding components

A$ million

MetricFY2025
R&D tax incentive receipts0.415
Exploration cash expenditure(1.179)
Supplier and employee payments(1.385)
Gross equity cash receipts0.900
Cash issue costs(0.080)
Lease repayments(0.006)

Selected components, not a full cash reconciliation. Lead-manager option accounting is non-cash: total share-capital transaction costs should not replace the cash-flow statement’s A$80,261 cash issue costs.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 04

Scrip consideration is not cash raised

NHM consideration included settlement shares valued at A$477,000 and milestone options valued at A$510,300. These non-cash amounts should not be counted as placement cash. The reported A$50,000 initial deposit is separately described, not silently added to the latest cash-flow categories.

FY2025 current liabilities were modest relative to current assets, but that does not eliminate the need to finance future exploration. An end-date liquidity comparison is not a forecast of funding sufficiency.

FY2025 liquidity and asset composition

A$ million

MetricFY2025
Cash and equivalents0.861
Term-deposit investments0.071
Current assets1.015
Current liabilities0.128
Capitalised exploration assets1.037
Total assets2.089
Total liabilities0.128

The term deposit is a separate reported asset; unrestricted availability is not assumed. Acquisition costs can be capitalised while ongoing exploration is expensed. The deposit, cash and asset subtotals are not additive categories.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Reading the figures

  • The FY2022 DB table linkage contains Australasian Metals content, not Aruma. All five previously unresolved flow cells were recovered from the correctly identified Aruma parsed original. This report correction does not repair the upstream DB linkage.
  • FY2023 group values are taken from Aruma FY2024 comparatives, not the Atlantic Lithium-labelled extraction. Historical source files remain unchanged.
  • FY2025 income uses correction decisions saved on 24 September 2026. On 28 September, only the residual FY2022 issues were checked against DB tables and existing parsed text; no PDF retrieval, reparsing or financial web research was undertaken.
  • The FY2022 operating cash reconciliation differs from its statement by A$1; FY2024 has a A$3 difference. The FY2025 equity comprehensive-loss total differs by A$2 from the income statement. The primary statement values are retained rather than force-balanced.
  • Primary-author review only; published and not independently audited.

Annual-report source registry

  • Aruma Resources Limited - Annual Report to shareholdersExisting extraction; FY2025 income also uses corrections saved 24 September 2026.
  • Aruma Resources Limited - Annual Report to shareholdersAruma FY2022 consolidated statements, existing Docling parse_content_id 2078556; cash-flow statement and loss/other-income notes. Character-range locators retained in the repair evidence. Foreign-company DB tables excluded.
  • Aruma Resources Limited - Annual ReportForeign-company extraction slice excluded; later same-company comparative/opening balances used where available.
  • Aruma Resources Limited - Annual Report to shareholdersExisting extraction; FY2025 income also uses corrections saved 24 September 2026.
  • Aruma Resources Limited - Annual ReportExisting extraction; FY2025 income also uses corrections saved 24 September 2026.

Prepared from the existing year-by-year extractions and saved corrections, supplemented by a specifically authorised DB-table and existing parsed-text lookup for residual issues on 28 September 2026. No PDFs were downloaded or reparsed and no financial web research was used. The lookup log and source locators are retained; this is not an independent audit.

Sources, copyright and independence

The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.

Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.

AI-led method

This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.

Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.

Information notice

This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.

It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.

Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.

Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.